{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:10:26Z","timestamp":1766182226133,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20393"],"award-info":[{"award-number":["U21A20393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD20011","ZYJC21001"],"award-info":[{"award-number":["ZYGD20011","ZYJC21001"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ChiCTR1900027074"],"award-info":[{"award-number":["ChiCTR1900027074"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2019-YF09-00215-SN"],"award-info":[{"award-number":["2019-YF09-00215-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111763","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T23:54:03Z","timestamp":1708991643000},"page":"111763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures"],"prefix":"10.1016","volume":"130","author":[{"given":"Wei","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jierui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-4125","authenticated-orcid":false,"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-8269","authenticated-orcid":false,"given":"Jinmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111763_b0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2024.111763_b0010","doi-asserted-by":"crossref","unstructured":"Tanaka K, Kawamura M, Sakimura K, Kato N. Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review. International journal of molecular sciences 2020;21.","DOI":"10.3390\/ijms21144941"},{"key":"10.1016\/j.intimp.2024.111763_b0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaneurol.2021.3113","article-title":"Discerning the role of autoimmunity and autoantibodies in epilepsy: a review","volume":"78","author":"Steriade","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12883-022-03042-0","article-title":"Early predictors of new-onset immune-related seizures: a preliminary study","volume":"22","author":"Shi","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/epi.17478","article-title":"Acute symptomatic seizures, epilepsy, and autoimmune encephalitis: clarifying terminology in neural antibody-associated disease","volume":"64","author":"Budhram","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/epi.14649","article-title":"Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability","volume":"60","author":"Dubey","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.26013","article-title":"Antibodies contributing to focal epilepsy signs and symptoms score","volume":"89","author":"de Bruijn","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/epi.16820","article-title":"Antibody prevalence in epilepsy before surgery (APES) in drug-resistant focal epilepsy","volume":"62","author":"Li","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jnnp-2020-325011","article-title":"Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies","volume":"92","author":"McGinty","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2024.111763_b0055","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/epi.17238","article-title":"\u201cObvious\u201d indications for neural antibody testing in epilepsy or seizures: the ONES checklist","volume":"63","author":"Chang","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0060","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2024.111763_b0065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/jnnp-2020-323841","article-title":"Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study","volume":"91","author":"Bozzetti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2024.111763_b0070","doi-asserted-by":"crossref","first-page":"e1590","DOI":"10.1212\/WNL.0000000000010318","article-title":"Neuronal antibody prevalence in children with seizures under 3 years: a prospective national cohort","volume":"95","author":"Symonds","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2024.111763_b0075","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/CM9.0000000000001701","article-title":"Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies","volume":"134","author":"Jia","year":"2021","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.intimp.2024.111763_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.111763_b0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0095","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.111763_b0110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fimmu.2019.00769","article-title":"Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations","volume":"10","author":"Ruiz-Garc\u00eda","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111763_b0115","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fimmu.2020.01482","article-title":"The diagnostic value of onconeural antibodies depends on how they are tested","volume":"11","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111763_b0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0130","doi-asserted-by":"crossref","unstructured":"Hinson SR, Lopez-Chiriboga AS, Bower JH, et al. Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders. Neurology(R) Neuroimmunol. Neuroinflam. 2018;5:e438.","DOI":"10.1212\/NXI.0000000000000438"},{"key":"10.1016\/j.intimp.2024.111763_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.111763_b0145","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features","volume":"91","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2024.111763_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102011","article-title":"Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature","volume":"41","author":"Foiadelli","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2024.111763_b0155","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/cns.13738","article-title":"BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder","volume":"27","author":"Yin","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2024.111763_b0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.seizure.2020.07.021","article-title":"Application of the APE(2)-CHN and RITE(2)-CHN scores for autoimmune seizures and epilepsy in Chinese patients: a retrospective study","volume":"81","author":"Liu","year":"2020","journal-title":"Seizure"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924002819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924002819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:17:06Z","timestamp":1761589026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S1567576924002819"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111763","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111763"}}